Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell therapy for radiation-induced pulmonary fibrosis
ChiCTR1800019309Phase 2Not yet recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Jan 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cells in pulmonary fibrosis (PF) (2 arms), sponsored by Yunnan Cancer Hospital. Primary endpoint: Safety evaluation. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on ChiCTR1800019309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019309.